Study of Risk Factors for Intraductal Papillary Mucinous Neoplasms Degeneration at the Nancy CHRU (IPMN)
Clinical trial NCT04901364 · UNKNOWN
Trial details
- NCT number
- NCT04901364
- Sponsor
- Central Hospital, Nancy, France
- Status
- UNKNOWN
- Study type
- OBSERVATIONAL
- Start date
- 2021-05-10
- Primary completion
- 2021-09-30
- Enrollment
- 57
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.